Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-124785
Filing Date
2016-06-01
Accepted
2016-06-01 18:40:48
Documents
2
Period of Report
2016-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 11084
2 POA DOCUMENT poa.txt EX-24.3_658929 3952
  Complete submission text file 0001209191-16-124785.txt   16461
Mailing Address 1220 OLD ALPHARETTA RD SUITE 300 ALPHARETTA GA 30005
Business Address 1220 OLD ALPHARETTA RD SUITE 300 ALPHARETTA GA 30005 678-270-4005
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CLEARSIDE BIOMEDICAL, INC. 1220 OLD ALPHARETTA ROAD, SUITE 300 ALPHARETTA GA 30005
Business Address
Deignan Charles A. (Reporting) CIK: 0001664690 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37783 | Film No.: 161690499